Brief: Alzinova Progresses Following Positive Pre-Ind Meeting With FDA

Alzinova AB

09/08/2023 07:14

Aug 9 (Reuters) - Alzinova AB  ALZ.ST :
    * ALZINOVA PROGRESSES FOLLOWING POSITIVE PRE-IND MEETING
WITH FDA
    * COMPANY HAS SUCCESSFULLY CONCLUDED PRE-IND MEETING WITH US
FOOD
AND DRUG ADMINISTRATION (FDA)
    * RECEIVING POSITIVE FEEDBACK ON PLANNED CLINICAL
DEVELOPMENT
PROGRAM FOR VACCINE CANDIDATE ALZ-101
    * REPRESENTS STEP FOR POTENTIAL PARTNERING DISCUSSIONS,
PATHWAY
TOWARDS SUBMISSION OF APPLICATION TO INCLUDE US STUDY CENTERS IN
FUTURE CLINICAL STUDIES

Source text for Eikon:  ID:nMFN6LxtXK 
Further company coverage:  ALZ.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))